Form D · Biotechnology
Drizzle Health, LLC
Baltimore, MD · CIK 0002045956
Offering snapshot reported Nov 10, 2026 · SEC filing
- Reported sold
- $600K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 2, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2026 | Initial | $600,000 | No comparison | 1 | SEC filing |
| Nov 26, 2024 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-604187
The securities being offered are simple agreements for future equity (SAFE)
Source: Form D, filed Nov 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yukari Manabe | Director |
| Bonolo Mathekga | Director, Executive, Promoter |
| Digvijay Singh | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
701 E Pratt Street Suite 2033
Baltimore, MD, 21202
Baltimore, MD, 21202